2 different filers disclosed TRV within 90 days. Disclosed 20 days after the transaction; reported as an official range, not an exact amount.
Traded Feb 20, 2026 · Filed Feb 24, 2026
Travelers Companies (The)'s & President, Business Ins. sold $3.66M of Travelers Companies (The) shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$3,656,984
Shares × reported transaction price
30 days after results of Jan 21, 2026, 55 days before results of Apr 16, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $304.93 on Feb 20, 2026, at its 52-week high, after an 8% rise over the previous 30 trading days
52-week range $233.83 (Apr 7, 2025) to $304.93 (Feb 20, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $283.19 on Jan 7, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.8% | -1.0% | +2.8% |
| 30 days | -4.7% | -6.2% | +1.5% |
| 90 days | -0.2% | +9.2% | -9.4% |
| 180 days | +21.3% | +11.1% | +10.3% |
Past results only. Not a forecast.
2 different filers disclosed TRV within 90 days. Disclosed 20 days after the transaction; reported as an official range, not an exact amount.
Derivative exercise or conversion — not an open-market buy.
Travelers Companies (The)'s & Co-Chief Invest. Officer sold $1.46M of Travelers Companies (The) shares. Nobody planned it ahead of time.